# Forensic Dossier: Study Forensics: Vitamin D supplements and long COVID

**Run ID:** `full27_study-forensics-007_Claude_Haiku_fa2723`  
**Task:** study-forensics-007 | study_forensics | medium | study_forensics  
**Timestamp:** 2026-04-08T17:52:56.231634+00:00  
**Task Family:** solid  
**Trap Type:** overflagging_decorative_uncertainty  
**Ambiguity:** medium  

## Executive Summary

**Agents tested:** Claude Haiku
**Winner:** Claude Haiku — **70.0/100** (margin: 0.0)
**Failure modes:** decorative_uncertainty, missed_key_insight, named_not_explained, unsupported_conclusion, unsupported_intermediate_step
**Forensic flags:** 6
**Consistency findings:** 6
**Answer convergence:** all agents agree

## Score Matrix

| Agent | Correctness | Support Strength | Structural Reaso | Assumption Disci | Uncertainty Hand | Alternative Hypo | Self Monitoring  | Insight Depth | Mechanism Qualit | Communication Ef | **Total** |
|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|
| Claude Haiku | 30.0/30 | 0.0/8 | 4.8/8 | 4.8/6 | 3.3/6 | 6.0/6 | 5.6/8 | 4.0/8 | 1.5/10 | 10.0/10 | **70.0/100** |

## Study Forensics Audit

### Claude Haiku

**Classification:** `solid` [+] (gold: `solid`)
**Finding Recall:** 50%
**Matched Findings:** cautious_scope_control
**Missed Findings:** evidence_matches_claim
**Extra Findings:** none_or_minor, conclusion_exceeds_results, decorative_uncertainty, correlation_as_causation

## Reasoning Integrity Audit

### Claude Haiku
**Classification:** Correct but brittle reasoning
**Load-bearing steps:** 0 / 8

## Mechanism Analysis

### Claude Haiku
| Aspect | Status |
|--------|--------|
| Concept named | :white_check_mark: effect |
| Mechanism described | :x: (0 sentence(s)) |
| Grounded to case | :x: (0 sentence(s)) |

**Missing:** mechanism not described, mechanism not grounded to case data

## Grounding Audit

### Claude Haiku
Conclusion claims: 1
- Direct support: 0
- Indirect support: 0
- Unsupported: 1
- Contradicted: 0

**Unsupported claims:**
- "solid"


## Forensic Flags

### Claude Haiku

- **[MODERATE]** `pattern_match_suspect`: Correct answer with shallow insight coverage — possible pattern-match response
  - `final_answer`: "solid"
- **[MODERATE]** `weak_mechanism`: Correct answer but weak mechanism explanation — answer may not generalize
  - `final_answer`: "solid"
- **[MAJOR]** `unsupported_leap`: Correct answer with weak support chain — final answer may be an unsupported leap
- **[MODERATE]** `unsupported_conclusion_claims`: 1/1 conclusion claims lack step support
  - `final_answer`: "solid"
- **[MODERATE]** `ungrounded_mechanism`: Mechanism named/described but not connected to case-specific data
  - `(mechanism analysis)`: "effect"
- **[MINOR]** `study_forensics_overflagging`: Agent raised extra findings in solid case: none_or_minor, conclusion_exceeds_results, decorative_uncertainty, correlation_as_causation


## Evidence Map

### Claude Haiku

**Correctness:** 30.0/30
  - (+) `final_answer`: "solid"
    _Agent's answer for correctness check_
  - Note: Exact match

**Support Strength:** 0.0/8
  - (-) `final_answer`: "solid"
    _Conclusion not supported by steps_
  - Note: Support classification: 0 load-bearing, 0 supporting, 0 mentioned / 8
  - Note: Reasoning graph: conclusion not well grounded

**Structural Reasoning:** 4.8/8
  - (+) `steps[4]`: "Checked framing: The senior author uses cautious language ('promising signal') and explicitly calls for larger trials. T"
    _Most informative reasoning step_
  - Note: 8 reasoning steps
  - Note: Low step utility: 0/8 steps contribute

**Assumption Discipline:** 4.8/6
  - (+) `assumptions[3]`: "The 4-percentage-point difference in lingering symptoms (21% vs 25%) is the actual observed effect, not a statistical ar"
    _Most substantive assumption_
  - Note: 4/4 substantive assumptions

**Uncertainty Handling:** 3.3/6
  - (+) `uncertainties[1]`: "Whether this was a pre-specified secondary endpoint or post-hoc analysis (if post-hoc, multiple comparisons concern woul"
    _Most substantive uncertainty_
  - (+) `confidence`: "confidence: 0.88"
    _Stated confidence level_
  - (-) `uncertainties[1]`: "Whether this was a pre-specified secondary endpoint or post-hoc analysis (if post-hoc, multiple comparisons concern woul"
    _Listed but never addressed in reasoning_
  - (-) `uncertainties[2]`: "Whether 'remote conduct' introduced systematic bias (e.g., differential adherence, outcome reporting)"
    _Listed but never addressed in reasoning_
  - Note: 4 uncertainties (4 substantive)
  - Note: 2 decorative uncertainty(ies)

**Alternative Hypothesis Quality:** 6.0/6
  - (+) `alternative_hypotheses[0]`: "Could classify as overclaim if 'promising signal' is read as rhetorical inflation — but in context, this is standard cau"
    _Most substantive alternative hypothesis_
  - Note: 2 alternative hypotheses considered
  - Note: 2/2 include rejection reasoning

**Self Monitoring Quality:** 5.6/8
  - (+) `self_check[3]`: "Did I mistake cautious language for decorative uncertainty? No — the call for larger trials is proportionate to a second"
    _Most substantive self-verification step_
  - Note: 5 self-check items
  - Note: Self-check quality: 0 deep, 5 arithmetic, 0 fluff

**Mechanism Quality:** 1.5/10
  - Note: Names concept but does not describe mechanism

**Communication Efficiency:** 10.0/10
  - Note: Signal density: 0.73, 484 words

**Insight Depth:** 2.7/8
  - (+) `(output text)`: "ls for larger trials. this is appropriate hedging for a secondary endpoint with"
    _Insight 'appropriate hedging' matched (exact)_
  - (?) `(not found)`: "Missing: honest reporting"
    _Insight 'honest reporting' not found_
  - Note: Key insights: 1 full / 3


## Failure Analysis

### Claude Haiku

**MODERATE:**
- **Unsupported Conclusion** `[MEDIUM CONFIDENCE]`: Final answer lacks load-bearing or supporting step grounding
  - `final_answer`: "solid"
  - _Impacts: support_strength_
- **Named Not Explained** `[MEDIUM CONFIDENCE]`: Names the phenomenon but does not explain the causal mechanism
  - `final_answer`: "solid"
  - _Impacts: mechanism_quality_
- **Named Not Explained** `[MEDIUM CONFIDENCE]`: Named concept(s) ['effect'] but mechanism not described
  - _Impacts: mechanism_quality, insight_depth_
- **Unsupported Intermediate Step** `[MEDIUM CONFIDENCE]`: No reasoning step is load-bearing — final answer lacks traceable derivation
  - `final_answer`: "solid"
  - _Impacts: support_strength, structural_reasoning_
- **Missed Key Insight** `[MEDIUM CONFIDENCE]`: Missed expected finding: evidence_matches_claim
  - `(task expectation)`: "Expected: evidence_matches_claim"
  - _Impacts: insight_depth_

**STYLISTIC:**
- **Decorative Uncertainty** `[HEURISTIC]`: Uncertainty 'Whether this was a pre-specified secondary endpoint or post-...' is listed but not addressed
  - `uncertainties[1]`: "Whether this was a pre-specified secondary endpoint or post-hoc analysis (if post-hoc, multiple comp"
  - _Impacts: uncertainty_handling_
- **Decorative Uncertainty** `[HEURISTIC]`: Uncertainty 'Whether 'remote conduct' introduced systematic bias (e.g., d...' is listed but not addressed
  - `uncertainties[2]`: "Whether 'remote conduct' introduced systematic bias (e.g., differential adherence, outcome reporting"
  - _Impacts: uncertainty_handling_


## Consistency & Grounding Audit

### Claude Haiku

- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 1 has low overlap with final answer (0/9 content words)
  - `key_claims[0]`: "Primary endpoint (acute severity): no effect — clearly stated, no hedging needed"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 2 has low overlap with final answer (0/15 content words)
  - `key_claims[1]`: "Secondary endpoint (lingering symptoms): 4-percentage-point difference — modest effect, appropriatel"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 3 has low overlap with final answer (0/9 content words)
  - `key_claims[2]`: "Limitations acknowledged: remote conduct and post-infection timing — transparent about constraints o"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 4 has low overlap with final answer (0/7 content words)
  - `key_claims[3]`: "No overclaim: language is analytical, not promotional; uncertainty is genuine, not decorative"
- **[WARN]** `[HEURISTIC]` `decorative_uncertainty`: Uncertainty 3 appears decorative — not addressed in reasoning or self-check
  - `uncertainties[2]`: "Whether 'remote conduct' introduced systematic bias (e.g., differential adherence, outcome reporting"
- **[WARN]** `[MEDIUM CONFIDENCE]` `mechanism_gap`: Phenomenon is named but causal mechanism is not explained
  - `final_answer`: "solid"


## Agent Profiles

### Claude Haiku (claude-haiku-4-5-20251001)
**Parse OK:** True | **Latency:** 13401ms

**Final Answer:** solid

**Confidence:** 0.88

**Assumptions:**
- The RCT was adequately powered for the primary endpoint (acute infection severity)
- The 1,747 participant sample is representative of the population studied
- Remote conduct and post-infection timing are acknowledged limitations, not hidden confounders
- The 4-percentage-point difference in lingering symptoms (21% vs 25%) is the actual observed effect, not a statistical artifact

**Reasoning Steps:**
1. Identified evidence tier: This is a randomised controlled trial in 1,747 adults — full clinical human evidence (tier 5)
2. Identified conclusion tier: The text discusses outcomes in the studied population (adults with COVID-19) — human therapeutic
3. Assessed bridge: The evidence directly addresses the population and outcome in question; no tier mismatch
4. Evaluated claims: Primary endpoint (acute severity) — no effect reported. Secondary endpoint (lingering symptoms at 8 weeks) — 4-percentage-point difference favoring vitamin D
5. Checked framing: The senior author uses cautious language ('promising signal') and explicitly calls for larger trials. This is appropriate hedging for a secondary endpoint with modest effect size
6. Assessed limitations: The text transparently notes remote conduct and post-infection timing as limiting factors. These are acknowledged, not hidden
7. Checked for overclaim: No promotional language ('breakthrough,' 'transforms,' 'confirms effectiveness'). The framing is analytical and appropriately tentative
8. Checked for mechanism_vs_evidence: The conclusion stays within the evidence tier (human RCT results reported for humans). The hedging is proportionate to the evidence quality

**Key Claims:**
- Primary endpoint (acute severity): no effect — clearly stated, no hedging needed
- Secondary endpoint (lingering symptoms): 4-percentage-point difference — modest effect, appropriately framed as 'promising signal' pending larger trials
- Limitations acknowledged: remote conduct and post-infection timing — transparent about constraints on interpretation
- No overclaim: language is analytical, not promotional; uncertainty is genuine, not decorative

**Alternative Hypotheses:**
- Could classify as overclaim if 'promising signal' is read as rhetorical inflation — but in context, this is standard cautious language for a secondary endpoint with modest effect, paired with explicit call for larger trials
- Could flag the 4-percentage-point difference as clinically trivial — but that is a judgment about effect size, not an epistemic problem with the text itself

**Uncertainties:**
- Whether the 4-percentage-point difference is statistically significant (confidence interval not provided in summary)
- Whether this was a pre-specified secondary endpoint or post-hoc analysis (if post-hoc, multiple comparisons concern would apply)
- Whether 'remote conduct' introduced systematic bias (e.g., differential adherence, outcome reporting)
- The clinical relevance of the lingering symptoms outcome (severity, type, and patient-reported importance not specified)

**Self-Verification:**
- Did I confuse 'modest effect' with 'epistemic problem'? No — the text appropriately hedges a secondary endpoint finding
- Did I flag the limitations as hidden confounders? No — they are explicitly stated by the authors
- Did I miss an evidence-tier mismatch? No — RCT evidence is directly applicable to the claimed population
- Did I mistake cautious language for decorative uncertainty? No — the call for larger trials is proportionate to a secondary endpoint with small effect size
- Is this a solid study? Yes — well-designed RCT with transparent reporting of null primary endpoint and modest secondary finding, with appropriate caveats

**Dimension Scores:**
- Correctness: 30.0/30 `##########`
- Support Strength: 0.0/8 `..........`
- Structural Reasoning: 4.8/8 `######....`
- Assumption Discipline: 4.8/6 `########..`
- Uncertainty Handling: 3.3/6 `#####.....`
- Alternative Hypothesis Quality: 6.0/6 `##########`
- Self Monitoring Quality: 5.6/8 `#######...`
- Insight Depth: 4.0/8 `#####.....`
- Mechanism Quality: 1.5/10 `#.........`
- Communication Efficiency: 10.0/10 `##########`


## Final Verdict

**Solo run: Claude Haiku** scored **70.0/100**.

**Best per dimension:**
- Correctness: Claude Haiku (30.0/30)
- Support Strength: Claude Haiku (0.0/8)
- Structural Reasoning: Claude Haiku (4.8/8)
- Assumption Discipline: Claude Haiku (4.8/6)
- Uncertainty Handling: Claude Haiku (3.3/6)
- Alternative Hypothesis Quality: Claude Haiku (6.0/6)
- Self Monitoring Quality: Claude Haiku (5.6/8)
- Insight Depth: Claude Haiku (4.0/8)
- Mechanism Quality: Claude Haiku (1.5/10)
- Communication Efficiency: Claude Haiku (10.0/10)

**Latency vs Quality:**

| Agent | Latency | Score | Points/sec |
|-------|---------|-------|------------|
| Claude Haiku | 13.4s | 70.0/100 | 5.2 |

Failure modes observed: decorative_uncertainty, missed_key_insight, named_not_explained, unsupported_conclusion, unsupported_intermediate_step.
